Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
I would agree with you: imo CKD patients, SGLT2 inhibitors, and a composite MACE that includes HF will be the focus for BETonMACE2. I cannot see any other scenario. This is fundable by BP. So they will get there. But I doubt if the trial will start before 2021.
Meanwhile they will hope for the best with coronaviruses.
